A phase 2 trial of oral imatinib in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma in second or greater remission Academic Article uri icon

Overview

MeSH Major

  • Fallopian Tube Neoplasms
  • Neoplasm Recurrence, Local
  • Neoplasms, Glandular and Epithelial
  • Ovarian Neoplasms
  • Peritoneal Neoplasms
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines

abstract

  • Treatment with imatinib for patients with ovarian cancer in second CCR or greater did not prolong the PFS beyond the historical estimate.

publication date

  • December 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 19115680

Additional Document Info

start page

  • 568

end page

  • 72

volume

  • 29

number

  • 6